Human glutathione peroxidase codon 198 variant increases nasopharyngeal carcinoma risk and progression

Eur Arch Otorhinolaryngol. 2021 Oct;278(10):4027-4034. doi: 10.1007/s00405-021-06628-5. Epub 2021 Feb 22.

Abstract

Purpose: Glutathione peroxidase 1 (GPx-1) is a selenium-dependent detoxifying enzyme involved in the protection of cells against oxidative damage. Some genetic association studies reported significant associations between GPx-1 Pro198Leu variant and carcinogenesis across different populations; however, the impact of this variant on nasopharyngeal carcinoma (NPC) has not been explored. Therefore, the present study was planned to evaluate the potential involvement of the GPx-1 Pro198Leu variant and plasma GPx activity in the risk of developing NPC in a Tunisian population.

Methods: The GPx-1 Pro198Leu genotype was determined in 327 NPC patients and 150 healthy controls by the RFLP-PCR analysis. The correlation between the GPx-1 variant and the clinicopathological parameters was examined. GPx activity was assessed in the plasma of 119 NPC patients and 58 healthy control subjects and according to GPx-1 genotypes and clinicopathological characteristics of NPC patients.

Results: A significant association was found between GPx-1 Pro198Leu variant and NPC risk in a Tunisian population. The allelic frequencies of Pro and Leu alleles were 32% versus 68% and 41% versus 59% in NPC cases and controls, respectively. Thus, the minor 198 Leu allele increased significantly in NPC patients and appeared as a potential risk factor for NPC occurrence (OR = 1.48, CI 95% = 1.14-1.91, p = 0.002). The plasma GPx activity was significantly higher in NPC patients than in controls (p = 0.03). According to the clinicopathological characteristics of NPC patients, GPx activity decreased significantly in patients with lymph node metastasis (p = 0.004).

Conclusion: This is the first study showing a strong association between GPx-1 Pro198Leu genetic variant and NPC risk. GPx-1 Pro198Leu variant increased the development of regional lymph node metastasis. Plasma GPx activity was higher in NPC patients. Thus, GPx-1 gene could be considered as a determinant factor influencing NPC risk and progression.

Keywords: 198Leu mutation; Clinicopathological parameters; Gpx-1 gene; Nasopharyngeal carcinoma; Plasma GPx activity.

MeSH terms

  • Case-Control Studies
  • Codon
  • Genetic Predisposition to Disease
  • Genotype
  • Glutathione Peroxidase / genetics*
  • Glutathione Peroxidase GPX1
  • Humans
  • Nasopharyngeal Carcinoma / genetics
  • Nasopharyngeal Neoplasms* / genetics
  • Risk Factors

Substances

  • Codon
  • Glutathione Peroxidase
  • Glutathione Peroxidase GPX1
  • GPX1 protein, human